Results 281 to 290 of about 245,199 (308)

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

Lancet, The, 2014
Paul Emery, Ronald F Van Vollenhoven, Karel Pavelka   +2 more
exaly  

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

Lancet, The, 2019
Paul Emery, William F C Rigby, Yoshiya Tanaka   +2 more
exaly  

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial

Lancet, The, 2016
Thasia G Woodworth, Corrado A Bernasconi, Reinhard Bos   +2 more
exaly  

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial

Lancet, The, 2016
Nicolino Ruperto, Angela Pistorio, Francesco Zulian   +2 more
exaly  

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

Lancet, The, 2004
Lars Klareskog, Désirée M Van Der Heijde, Karel Pavelka   +2 more
exaly  

An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2017
Richard B Warren, Ulrich Mrowietz, Dagmar Wilsmann-Theis   +2 more
exaly  

METHOTREXATE SYSTEMIC CLEARANCE INFLUENCES PROBABILITY OF RELAPSE IN CHILDREN WITH STANDARD-RISK ACUTE LYMPHOCYTIC LEUKAEMIA

Lancet, The, 1984
Chen-Hsin Chen
exaly  

Methotrexate osteopathy

Joint Bone Spine
Daniel Wendling, Mickael Chouk, Olivier Fakih, Frank Verhoeven, Clément Prati   +4 more
openaire   +2 more sources

Methotrexate

Reactions Weekly, 2009
openaire   +2 more sources

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

Lancet, The, 2012
Kristina Forslind, Ingemar If Petersson, Katerina Chatzidionysiou   +2 more
exaly